149
Participants
Start Date
November 1, 2017
Primary Completion Date
January 31, 2020
Study Completion Date
February 1, 2021
ketoanalogues of essential amino acids
Patients will receive conventional treatment according to the institution's clinical guidelines, with moderate restriction of proteins 0.6 g protein/kg/day, as recommended to slow renal damage progression), plus ketoanalogues in the established dosage (1 tablet/5 kg weight divided into 3 doses per day).
Unidad de Investigación Médica en Enfermedades Nefrológicas, Instituto Mexicano del Seguro Social, Mexico City
Unidad de Investigacion Medica en Enfermedades Nefrologicas, Hospital de Especialidades Centro Medico Nacional Siglo XXI, Mexico City
Collaborators (1)
Fresenius Kabi
INDUSTRY
Coordinación de Investigación en Salud, Mexico
OTHER_GOV